Enhancement of peroxisomal beta-oxidation in the liver of rats and mice treated with valproic acid - PubMed (original) (raw)
Enhancement of peroxisomal beta-oxidation in the liver of rats and mice treated with valproic acid
S Horie et al. Biochem Pharmacol. 1985.
Abstract
The effects of valproic acid on peroxisomal beta-oxidation and on lipid levels of liver and serum in the rat and mouse were studied. When the animals were fed diet containing 1% valproic acid for 2 weeks, the activity of peroxisomal beta-oxidation increased 4-fold in the rat liver and 2-fold in the mouse liver. Other peroxisomal enzymes such as catalase and urate oxidase also increased by the treatment though to a lesser extent than beta-oxidation. The contents of triglyceride and cholesterol in the serum decreased significantly in the rat but not in the mouse. The time course curves of the activities of cyanide-insensitive palmitoyl-CoA oxidation and carnitine-dependent palmitoyltransferase indicated that peroxisomal beta-oxidation was enhanced more rapidly than that of mitochondrial. The distributions of these enzymes were not changed by the treatment with valproic acid, though increases in liver weight and protein content were observed. These results indicate that the action of valproic acid in enhancing hepatic beta-oxidation is similar to that of clofibrate and other hypolipidemic drugs.
Similar articles
- Effect of dehydroepiandrosterone treatment on liver metabolism in rats.
Cleary MP. Cleary MP. Int J Biochem. 1990;22(3):205-10. doi: 10.1016/0020-711x(90)90331-v. Int J Biochem. 1990. PMID: 1970539 Review. - Valproate and mitochondria.
Ponchaut S, Veitch K. Ponchaut S, et al. Biochem Pharmacol. 1993 Jul 20;46(2):199-204. doi: 10.1016/0006-2952(93)90404-k. Biochem Pharmacol. 1993. PMID: 8347141 Review. No abstract available.
Cited by
- Adjunct divalproex or lithium to clozapine in treatment-resistant schizophrenia.
Kelly DL, Conley RR, Feldman S, Yu Y, McMahon RP, Richardson CM. Kelly DL, et al. Psychiatr Q. 2006 Spring;77(1):81-95. doi: 10.1007/s11126-006-7963-9. Psychiatr Q. 2006. PMID: 16397757 - Assessment of asymmetric dimethylarginine and homocysteine in epileptic children receiving antiepileptic drugs.
Mahmoud AA, Aboelghar HM, Abdelmageed SM, Abdallah HM, Garib MI, Abd El Hady NMS. Mahmoud AA, et al. Pediatr Res. 2022 Dec;92(6):1606-1612. doi: 10.1038/s41390-022-02132-6. Epub 2022 Jun 10. Pediatr Res. 2022. PMID: 35688962 Free PMC article. - Neuronal peroxisome proliferator-activated receptor gamma signaling: regulation by mood-stabilizer valproate.
Lan MJ, Yuan P, Chen G, Manji HK. Lan MJ, et al. J Mol Neurosci. 2008 Jun;35(2):225-34. doi: 10.1007/s12031-008-9056-8. Epub 2008 Apr 25. J Mol Neurosci. 2008. PMID: 18437585 Free PMC article. - Effects of phthalic acid esters on the liver and thyroid.
Hinton RH, Mitchell FE, Mann A, Chescoe D, Price SC, Nunn A, Grasso P, Bridges JW. Hinton RH, et al. Environ Health Perspect. 1986 Dec;70:195-210. doi: 10.1289/ehp.8670195. Environ Health Perspect. 1986. PMID: 3830106 Free PMC article. - Biochemical relationships between Reye's and Reye's-like metabolic and toxicological syndromes.
Osterloh J, Cunningham W, Dixon A, Combest D. Osterloh J, et al. Med Toxicol Adverse Drug Exp. 1989 Jul-Aug;4(4):272-94. doi: 10.1007/BF03259913. Med Toxicol Adverse Drug Exp. 1989. PMID: 2671597 Review.